Micronutrient interactions -
The micronutrients are also are related to the uptake of macros. Adequate boron is needed for effective nitrogen fixation and nodulation in legume crops, while phosphorus and iron work together to increase the uptake of both of these nutrients.
This is called synergy. It is also good to keep in mind that calcium, a secondary nutrient, increases the uptake of both the macros and the micros.
Applied calcium increases the uptake of manganese, phosphorus, zinc, boron, magnesium, iron and potassium. Balancing nutrients to grow a good crop can be a challenging task, but your OMEX representative can guide you in choosing the Primers , Starters and Foliars that can help you meet your yield goals.
Home Blog Latest News Interaction Between the Micronutrients. Here are some of the key roles that micronutrients play: Boron is an essential component of cell wall formation and is key to the germination of pollen grains and growth of pollen tubes.
Zinc aids plant growth hormones and enzyme system, and is necessary for chlorophyll production and carbohydrate formation.
Copper plays a major role in photosynthesis. This element improves the flavour of fruits and vegetables and can help prevent ergot in cereals. Clin Biochem Rev. Young IS, Goh EM, McKillop UH, Stanford CF, Nicholls DP, Trimble ER. Magnesium status and digoxin toxicity.
Br J Clin Pharmacol. Pinto J, Raiczyk GB, Huang YP, Rivlin RS. New approaches to the possible prevention of side effects of chemotherapy by nutrition. Solecki TJ, Aviv A, Bogden JD. Effect of a chelating drug on balance and tissue distribution of four essential metals.
De Palma P, Franco F, Bragliani G, et al. The incidence of optic neuropathy in 84 patients treated with ethambutol. Metab Pediatr Syst Ophthalmol Melamud A, Kosmorsky GS, Lee MS. Ocular ethambutol toxicity. Mayo Clin Proc. Kaimbo WK, Bifuko ZA, Longo MB, Dralands L, Missotten L.
Color vision in 42 Congolese patients with tuberculosis receiving ethambutol treatment. Bull Soc Belge Ophtalmol. Stevens HP, Ostlere LS, Begent RH, Dooley JS, Rustin MH.
Pellagra secondary to 5-fluorouracil. Br J Dermatol. Hegyi J, Schwartz RA, Hegyi V. Pellagra: dermatitis, dementia, and diarrhea.
Int J Dermatol. Conahan C, Booth S, Hartley M, Okpoebo A, Sun J. Pellagra secondary to GI malignancy and fluorouracil-based chemotherapy. J Oncol Pract. Aksoy M, Basu TK, Brient J, Dickerson JW.
Thiamin status of patients treated with drug combinations containing 5-fluorouracil. Eur J Cancer. Vitamins - cytotoxic drug interaction. Valuck RJ, Ruscin JM. A case-control study on adverse effects: H2 blocker or proton pump inhibitor use and risk of vitamin B12 deficiency in older adults.
J Clin Epidemiol. Termanini B, Gibril F, Sutliff VE, Yu F, Venzon DJ, Jensen RT. Effect of long-term gastric acid suppressive therapy on serum vitamin B12 levels in patients with Zollinger-Ellison syndrome. Am J Med. Yang YX. Chronic proton pump inihibitor therapy and calcium metabolism. Curr Gastroenterol Rep.
Lam JR, Schneider JL, Quesenberry CP, Corley DA. Proton pump inhibitor and histamine-2 receptor antagonist use and iron deficiency. Bays HE, Dujovne CA. Drug interactions of lipid-altering drugs. Drug Saf. AIM-HIGH Investigators, Boden WE, Probstfield JL, et al.
Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy. Arsenio L, Bodria P, Magnati G, Strata A, Trovato R. Effectiveness of long-term treatment with pantethine in patients with dyslipidemia.
Evans M, Rumberger JA, Azumano I, Napolitano JJ, Citrolo D, Kamiya T. Pantethine, a derivative of vitamin B5, favorably alters total, LDL and non-HDL cholesterol in low to moderate cardiovascular risk subjects eligible for statin therapy: a triple-blinded placebo and diet-controlled investigation.
Vasc Health Risk Manag. Bailey DG, Dresser G, Arnold JM. Grapefruit-medication interactions: forbidden fruit or avoidable consequences? Moruisi KG, Oosthuizen W, Opperman AM. J Am Coll Nutr. Ras RT, Geleijnse JM, Trautwein EA.
LDL-cholesterol-lowering effect of plant sterols and stanols across different dose ranges: a meta-analysis of randomised controlled studies. Br J Nutr. Feiwel M, Harrison RJ. Pellagra caused by isoniazid.
Br Med J. Bilgili SG, Karadag AS, Calka O, Altun F. Isoniazid-induced pellagra. Cutan Ocul Toxicol. Post FA. Pellagra: a rare complication of isoniazid therapy. Int J Tuberc Lung Dis. Darvay A, Basarab T, McGregor JM, Russell-Jones R.
Isoniazid induced pellagra despite pyridoxine supplementation. Clin Exp Dermatol. McConnell RB, Cheetham HD. Acute pellagra during isoniazid therapy.
Snider DE, Jr. Pyridoxine supplementation during isoniazid therapy. Biehl JP, Vilter RW. Effects of isoniazid on pyridoxine metabolism.
J Am Med Assoc. Eggermont E, Logghe N, Van De Casseye W, et al. Haemorrhagic disease of the newborn in the offspring of rifampicin and isoniazid treated mothers.
Acta Paediatr Belg. Glass AR, Eil C. Ketoconazole-induced reduction in serum 1,dihydroxyvitamin D. J Clin Endocrinol Metab. Ketoconazole-induced reduction in serum 1,dihydroxyvitamin D and total serum calcium in hypercalcemic patients.
Adams JS, Sharma OP, Diz MM, Endres DB. Ketoconazole decreases the serum 1,dihydroxyvitamin D and calcium concentration in sarcoidosis-associated hypercalcemia. Hu XW, Qin SM, Li D, Hu LF, Liu CF. Elevated homocysteine levels in levodopa-treated idiopathic Parkinson's disease: a meta-analysis.
Acta Neurol Scand. Rogers JD, Sanchez-Saffon A, Frol AB, Diaz-Arrastia R. Elevated plasma homocysteine levels in patients treated with levodopa: association with vascular disease. Arch Neurol. Papavasiliou PS, Cotzias GC, Duby SE, Steck AJ, Fehling C, Bell MA.
Levodopa in Parkinsonism: potentiation of central effects with a peripheral inhibitor. Ebadi M, Gessert CF, Al-Sayegh A. Drug-pyridoxal phosphate interactions. Q Rev Drug Metab Drug Interact. Duvoisin RC, Yahr MD, Cote LD.
Pyridoxine reversal of L-dopa effects in Parkinsonism. Trans Am Neurol Assoc. Campbell NR, Hasinoff B. Ferrous sulfate reduces levodopa bioavailability: chelation as a possible mechanism. Campbell NR, Rankine D, Goodridge AE, Hasinoff BB, Kara M.
Sinemet-ferrous sulphate interaction in patients with Parkinson's disease. Schneyer CR. Calcium carbonate and reduction of levothyroxine efficacy. Singh N, Singh PN, Hershman JM. Effect of calcium carbonate on the absorption of levothyroxine. Zamfirescu I, Carlson HE.
Absorption of levothyroxine when coadministered with various calcium formulations. Benvenga S, Di Bari F, Vita R. Undertreated hypothyroidism due to calcium or iron supplementation corrected by oral liquid levothyroxine. Campbell NR, Hasinoff BB, Stalts H, Rao B, Wong NC.
Ferrous sulfate reduces thyroxine efficacy in patients with hypothyroidism. Shakir KM, Chute JP, Aprill BS, Lazarus AA.
Ferrous sulfate-induced increase in requirement for thyroxine in a patient with primary hypothyroidism. South Med J. Shopsin B, Shenkman L, Blum M, Hollander CS.
Iodine and lithium-induced hypothyroidism. Documentation of synergism. Perlman BB. Interaction between lithium salts and ispaghula husk.
Sheehan J, White A. Diuretic-associated hypomagnesaemia. Br Med J Clin Res Ed. Lim P, Jacob E. Magnesium deficiency in patients on long-term diuretic therapy for heart failure. Martin BJ, Milligan K. Diuretic-associated hypomagnesemia in the elderly. Arch Intern Med. Sica DA.
Diuretic-related side effects: development and treatment. J Clin Hypertens Greenwich. Zenuk C, Healey J, Donnelly J, Vaillancourt R, Almalki Y, Smith S. Thiamine deficiency in congestive heart failure patients receiving long term furosemide therapy.
Can J Clin Pharmacol. Suter PM, Haller J, Hany A, Vetter W. Diuretic use: a risk for subclinical thiamine deficiency in elderly patients. J Nutr Health Aging. Hanninen SA, Darling PB, Sole MJ, Barr A, Keith ME.
The prevalence of thiamin deficiency in hospitalized patients with congestive heart failure. J Am Coll Cardiol. Bauman WA, Shaw S, Jayatilleke E, Spungen AM, Herbert V. Increased intake of calcium reverses vitamin B12 malabsorption induced by metformin.
Diabetes Care. Gin H, Orgerie MB, Aubertin J. The influence of Guar gum on absorption of metformin from the gut in healthy volunteers.
Horm Metab Res. Campbell N, Paddock V, Sundaram R. Alteration of methyldopa absorption, metabolism, and blood pressure control caused by ferrous sulfate and ferrous gluconate. Campbell NR, Campbell RR, Hasinoff BB.
Ferrous sulfate reduces methyldopa absorption: methyldopa: iron complex formation as a likely mechanism. Clin Invest Med. Lambie DG, Johnson RH. Drugs and folate metabolism. Lindenbaum J. Drugs and vitamin B12 and folate metabolism. Visentin M, Zhao R, Goldman ID. The antifolates. Hematol Oncol Clin North Am.
Savage DG, Lindenbaum J. Neurological complications of acquired cobalamin deficiency: clinical aspects. Baillieres Clin Haematol. Massey TH, Pickersgill TT, K JP. Nitrous oxide misuse and vitamin B12 deficiency. BMJ Case Rep.
Koonsvitsky BP, Berry DA, Jones MB, et al. Olestra affects serum concentrations of alpha-tocopherol and carotenoids but not vitamin D or vitamin K status in free-living subjects.
Schlagheck TG, Riccardi KA, Zorich NL, Torri SA, Dugan LD, Peters JC. Olestra dose response on fat-soluble and water-soluble nutrients in humans. Neuhouser ML, Rock CL, Kristal AR, et al.
Olestra is associated with slight reductions in serum carotenoids but does not markedly influence serum fat-soluble vitamin concentrations. Melia AT, Koss-Twardy SG, Zhi J. The effect of orlistat, an inhibitor of dietary fat absorption, on the absorption of vitamins A and E in healthy volunteers. J Clin Pharmacol.
Zhi J, Melia AT, Koss-Twardy SG, Arora S, Patel IH. The effect of orlistat, an inhibitor of dietary fat absorption, on the pharmacokinetics of beta-carotene in healthy volunteers. McDuffie JR, Calis KA, Booth SL, Uwaifo GI, Yanovski JA. Effects of orlistat on fat-soluble vitamins in obese adolescents.
Drent ML, van der Veen EA. Lipase inhibition: a novel concept in the treatment of obesity. Int J Obes Relat Metab Disord. Tonstad S, Pometta D, Erkelens DW, et al. The effect of the gastrointestinal lipase inhibitor, orlistat, on serum lipids and lipoproteins in patients with primary hyperlipidaemia.
Eur J Clin Pharmacol. Rumsby PC, Shepherd DM. The effect of penicillamine on vitamin B6 function in man. Pool KD, Feit H, Kirkpatrick J. Penicillamine-induced neuropathy in rheumatoid arthritis.
Osman MA, Patel RB, Schuna A, Sundstrom WR, Welling PG. Reduction in oral penicillamine absorption by food, antacid, and ferrous sulfate. Harkness JA, Blake DR. Penicillamine nephropathy and iron. Brewer GJ, Dick RD, Johnson VD, Brunberg JA, Kluin KJ, Fink JK. Treatment of Wilson's disease with zinc: XV long-term follow-up studies.
Lewis DP, Van Dyke DC, Willhite LA, Stumbo PJ, Berg MJ. Phenytoin-folic acid interaction. Ann Pharmacother. Xu Y, Zhang N, Xu S, Xu H, Chen S, Xia Z. Effects of phenytoin on serum levels of homocysteine, vitamin B12, folate in patients with epilepsy: A systematic review and meta-analysis PRISMA-compliant article.
Medicine Baltimore. Linnebank M, Moskau S, Semmler A, et al. Antiepileptic drugs interact with folate and vitamin B12 serum levels. Ann Neurol. Botez MI, Joyal C, Maag U, Bachevalier J.
Low blood thiamine levels in phenytoin-treated epileptics. Nutrition Reports International. Cerebrospinal fluid and blood thiamine concentrations in phenytoin-treated epileptics. Can J Neurol Sci.
Hansson O, Sillanpaa M. Letter: Pyridoxine and serum concentration of phenytoin and phenobarbitone. Bell RD, Pak CY, Zerwekh J, Barilla DE, Vasko M. Effect of phenytoin on bone and vitamin D metabolism.
Patil MM, Sahoo J, Kamalanathan S, Pillai V. Phenytoin induced osteopathy - too common to be neglected. J Clin Diagn Res. Gough H, Goggin T, Bissessar A, Baker M, Crowley M, Callaghan N.
A comparative study of the relative influence of different anticonvulsant drugs, UV exposure and diet on vitamin D and calcium metabolism in out-patients with epilepsy.
Q J Med. Thorp JA, Gaston L, Caspers DR, Pal ML. Current concepts and controversies in the use of vitamin K. Velpandian T, Jasuja R, Bhardwaj RK, Jaiswal J, Gupta SK. Piperine in food: interference in the pharmacokinetics of phenytoin.
Eur J Drug Metab Pharmacokinet. Bano G, Amla V, Raina RK, Zutshi U, Chopra CL. The effect of piperine on pharmacokinetics of phenytoin in healthy volunteers. Planta Med. Corcino J, Waxman S, Herbert V. Mechanism of triamterene-induced megaloblastosis. Leary WP, Reyes AJ, van der Byl K.
Urinary magnesium and zinc excretions after two different single doses of amiloride in healthy adults. Curr Ther Res.
Reyes AJ, Olhaberry JV, Leary WP, Lockett CJ, van der Byl K. Urinary zinc excretion, diuretics, zinc deficiency and some side-effects of diuretics. S Afr Med J. Golik A, Modai D, Weissgarten J, et al. Hydrochlorothiazide-amiloride causes excessive urinary zinc excretion. Dharmarajan TS, Kanagala MR, Murakonda P, Lebelt AS, Norkus EP.
Do acid-lowering agents affect vitamin B12 status in older adults? J Am Med Dir Assoc. Wilhelm SM, Rjater RG, Kale-Pradhan PB. Perils and pitfalls of long-term effects of proton pump inhibitors. Expert Rev Clin Pharmacol. Cervelli MJ, Shaman A, Meade A, Carroll R, McDonald SP.
Effect of gastric acid suppression with pantoprazole on the efficacy of calcium carbonate as a phosphate binder in haemodialysis patients.
Nephrology Carlton. Van Delden C, Hirschel B. Folinic acid supplements to pyrimethamine-sulfadiazine for Toxoplasma encephalitis are associated with better outcome. J Infect Dis. Nzila A, Okombo J, Molloy AM. J Antimicrob Chemother.
Pletz MW, Petzold P, Allen A, Burkhardt O, Lode H. Effect of calcium carbonate on bioavailability of orally administered gemifloxacin.
Antimicrob Agents Chemother. Prescott JD, Drake VJ, Stevens JF. Medications and micronutrients: identifying clinically relevant interactions and addressing nutritional needs.
J Pharm Technol. Neuhofel AL, Wilton JH, Victory JM, Hejmanowsk LG, Amsden GW. Lack of bioequivalence of ciprofloxacin when administered with calcium-fortified orange juice: a new twist on an old interaction.
Frost RW, Lasseter KC, Noe AJ, Shamblen EC, Lettieri JT. Effects of aluminum hydroxide and calcium carbonate antacids on the bioavailability of ciprofloxacin.
Sahai J, Healy DP, Stotka J, Polk RE. The influence of chronic administration of calcium carbonate on the bioavailability of oral ciprofloxacin. Lehto P, Kivisto KT, Neuvonen PJ. The effect of ferrous sulphate on the absorption of norfloxacin, ciprofloxacin and ofloxacin. Polk RE, Healy DP, Sahai J, Drwal L, Racht E.
Effect of ferrous sulfate and multivitamins with zinc on absorption of ciprofloxacin in normal volunteers. Nix DE, Watson WA, Lener ME, et al. Effects of aluminum and magnesium antacids and ranitidine on the absorption of ciprofloxacin.
Hoffken G, Lode H, Wiley R, et al. Pharmacokinetics and bioavailability of ciprofloxacin and ofloxacin: effect of food and antacid intake. Reviews of Infectious Diseases. Hoffken G, Borner K, Glatzel PD, Koeppe P, Lode H. Reduced enteral absorption of ciprofloxacin in the presence of antacids.
Eur J Clin Microbiol. Brodie MJ, Boobis AR, Dollery CT, et al. Rifampicin and vitamin D metabolism. Jansen G, van der Heijden J, Oerlemans R, et al. Sulfasalazine is a potent inhibitor of the reduced folate carrier: implications for combination therapies with methotrexate in rheumatoid arthritis.
Arthritis Rheum. Halsted CH, Gandhi G, Tamura T. Sulfasalazine inhibits the absorption of folates in ulcerative colitis. Natural Medicines. Neuvonen PJ. Interactions with the absorption of tetracyclines.
Andersson KE, Bratt L, Dencker H, Kamme C, Lanner E. Inhibition of tetracycline absorption by zinc. Penttila O, Hurme H, Neuvonen PJ. Effect of zinc sulphate on the absorption of tetracycline and doxycycline in man. Brickman AS, Massry SG, Coburn JW. Changes in serum and urinary calcium during treatment with hydrochlorothiazide: studies on mechanisms.
Rodenburg EM, Visser LE, Hoorn EJ, et al. Thiazides and the risk of hypokalemia in the general population. J Hypertens. Pak CY, Ruskin B, Diller E. Enhancement of renal excretion of zinc by hydrochlorothiazide. Clin Chim Acta. Wester PO. Urinary zinc excretion during treatment with different diuretics.
Schweitzer BI, Dicker AP, Bertino JR. Dihydrofolate reductase as a therapeutic target. FASEB J. Meidahl Petersen K, Eplov K, Kjaer Nielsen T, et al.
The effect of trimethoprim on serum folate levels in humans: a randomized, double-blind, placebo-controlled trial. Am J Ther. Kahn SB, Fein SA, Brodsky I. Effects of trimethoprim on folate metabolism in man.
Kinzie BJ, Taylor JW. Trimethoprim and folinic acid. Opala G, Winter S, Vance C, Vance H, Hutchison HT, Linn LS.
The effect of valproic acid on plasma carnitine levels. Am J Dis Child. Van Wouwe JP. Carnitine deficiency during valproic acid treatment. Int J Vitam Nutr Res. Lheureux PE, Hantson P. Carnitine in the treatment of valproic acid-induced toxicity.
Clin Toxicol Phila. Moser LR, Smythe MA, Tisdale JE. The use of calcium salts in the prevention and management of verapamil-induced hypotension. Rosenthal G. Interaction of ascorbic acid and warfarin. Smith EC, Skalski RJ, Johnson GC, Rossi GV. Booth SL, Golly I, Sacheck JM, et al.
Effect of vitamin E supplementation on vitamin K status in adults with normal coagulation status. Holmes MV, Hunt BJ, Shearer MJ. The role of dietary vitamin K in the management of oral vitamin K antagonists.
Blood Rev. Violi F, Lip GY, Pignatelli P, Pastori D. Interaction between dietary vitamin K intake and anticoagulation by vitamin K antagonists: is it really true?
Holbrook AM, Pereira JA, Labiris R, et al. Systematic overview of warfarin and its drug and food interactions. Lambert JP, Cormier J. Potential interaction between warfarin and boldo-fenugreek. Teng CM, Hsueh CM, Chang YL, Ko FN, Lee SS, Liu KC. Antiplatelet effects of some aporphine and phenanthrene alkaloids in rabbits and man.
J Pharm Pharmacol. Wittkowsky AK. A systematic review and inventory of supplement effects on warfarin and other anticoagulants. Thromb Res. Huang SS, Sung SH, Chiang CE. Chitosan potentiation of warfarin effect.
Spigset O. Reduced effect of warfarin caused by ubidecarenone. Mohammed Abdul MI, Jiang X, Williams KM, et al. Pharmacodynamic interaction of warfarin with cranberry but not with garlic in healthy subjects. Br J Pharmacol. Lilja JJ, Backman JT, Neuvonen PJ.
Effects of daily ingestion of cranberry juice on the pharmacokinetics of warfarin, tizanidine, and midazolam--probes of CYP2C9, CYP1A2, and CYP3A4. Paeng CH, Sprague M, Jackevicius CA. Interaction between warfarin and cranberry juice. Rindone JP, Murphy TW. Warfarin-cranberry juice interaction resulting in profound hypoprothrombinemia and bleeding.
Li Z, Seeram NP, Carpenter CL, Thames G, Minutti C, Bowerman S. Cranberry does not affect prothrombin time in male subjects on warfarin. J Am Diet Assoc. Izzat MB, Yim AP, El-Zufari MH.
A taste of Chinese medicine! Ann Thorac Surg. Yu CM, Chan JC, Sanderson JE. Chinese herbs and warfarin potentiation by 'danshen'. J Intern Med. Zhou X, Chan K, Yeung JH. Herb-drug interactions with Danshen Salvia miltiorrhiza : a review on the role of cytochrome P enzymes.
Drug Metabol Drug Interact. Liu J, Wang X, Cai Z, Lee FS. Effect of tanshinone IIA on the noncovalent interaction between warfarin and human serum albumin studied by electrospray ionization mass spectrometry. J Am Soc Mass Spectrom.
Wu WW, Yeung JH. Inhibition of warfarin hydroxylation by major tanshinones of Danshen Salvia miltiorrhiza in the rat in vitro and in vivo. Lv C, Liu C, Yao Z, et al. The clinical pharmacokinetics and pharmacodynamics of warfarin when combined with compound danshen: a case study for combined treatment of coronary heart diseases with atrial fibrillation.
Front Pharmacol. Shaw D, Leon C, Kolev S, Murray V. Traditional remedies and food supplements. A 5-year toxicological study Page RL 2 nd , Lawrence JD.
Potentiation of warfarin by dong quai. Gorski JC, Huang SM, Pinto A, et al. The effect of echinacea Echinacea purpurea root on cytochrome P activity in vivo. Buckley MS, Goff AD, Knapp WE. Fish oil interaction with warfarin.
Pryce R, Bernaitis N, Davey AK, Badrick T, Anoopkumar-Dukie S. The use of fish oil with warfarin does not significantly affect either the international normalised ratio or incidence of adverse events in patients with atrial fibrillation and deep vein thrombosis: a retrospective study.
Sunter WH. Warfarin and garlic. Pharm J. Ackermann RT, Mulrow CD, Ramirez G, Gardner CD, Morbidoni L, Lawrence VA. Garlic shows promise for improving some cardiovascular risk factors.
Macan H, Uykimpang R, Alconcel M, et al. Aged garlic extract may be safe for patients on warfarin therapy. Kruth P, Brosi E, Fux R, Morike K, Gleiter CH. Ginger-associated overanticoagulation by phenprocoumon. Rubin D, Patel V, Dietrich E.
Effects of oral ginger supplementation on the INR. Case Rep Med. Jiang X, Williams KM, Liauw WS, et al. Effect of ginkgo and ginger on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects.
Bent S, Goldberg H, Padula A, Avins AL. Spontaneous bleeding associated with ginkgo biloba: a case report and systematic review of the literature: a case report and systematic review of the literature.
J Gen Intern Med. Engelsen J, Nielsen JD, Winther K. Effect of coenzyme Q10 and Ginkgo biloba on warfarin dosage in stable, long-term warfarin treated outpatients. A randomised, double blind, placebo-crossover trial.
Thromb Haemost. Kellermann AJ, Kloft C. Is there a risk of bleeding associated with standardized Ginkgo biloba extract therapy? A systematic review and meta-analysis. Janetzky K, Morreale AP.
Probable interaction between warfarin and ginseng. Am J Health Syst Pharm. Yuan CS, Wei G, Dey L, et al. Brief communication: American ginseng reduces warfarin's effect in healthy patients: a randomized, controlled Trial.
Lee YH, Lee BK, Choi YJ, Yoon IK, Chang BC, Gwak HS. Interaction between warfarin and Korean red ginseng in patients with cardiac valve replacement.
Int J Cardiol. Effect of St John's wort and ginseng on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects. Bartle WR. Grapefruit juice might still be factor in warfarin response. Sullivan DM, Ford MA, Boyden TW. Grapefruit juice and the response to warfarin. Taylor JR, Wilt VM.
Probable antagonism of warfarin by green tea. Monterrey-Rodriguez J. Interaction between warfarin and mango fruit. Leite PM, Martins MAP, Castilho RO. Review on mechanisms and interactions in concomitant use of herbs and warfarin therapy. Biomed Pharmacother. Jarvis S, Li C, Bogle RG. Possible interaction between pomegranate juice and warfarin.
Emerg Med J. Nagata M, Hidaka M, Sekiya H, et al. Effects of pomegranate juice on human cytochrome P 2C9 and tolbutamide pharmacokinetics in rats. Drug Metab Dispos. Pace-Asciak CR, Hahn S, Diamandis EP, Soleas G, Goldberg DM.
The red wine phenolics trans-resveratrol and quercetin block human platelet aggregation and eicosanoid synthesis: implications for protection against coronary heart disease.
Bertelli AA, Giovannini L, Giannessi D, et al. Antiplatelet activity of synthetic and natural resveratrol in red wine. Int J Tissue React.
Cambria-Kiely JA. Effect of soy milk on warfarin efficacy. Heck AM, DeWitt BA, Lukes AL. Potential interactions between alternative therapies and warfarin. Shah BH, Nawaz Z, Pertani SA, et al.
Hu S, Belcaro G, Dugall M, et al. Interaction study between antiplatelet agents, anticoagulants, thyroid replacement therapy and a bioavailable formulation of curcumin Meriva ®. Eur Rev Med Pharmacol Sci. The Linus Pauling Institute's Micronutrient Information Center provides scientific information on the health aspects of dietary factors and supplements, food, and beverages for the general public.
The information is made available with the understanding that the author and publisher are not providing medical, psychological, or nutritional counseling services on this site. The information should not be used in place of a consultation with a competent health care or nutrition professional.
The information on dietary factors and supplements, food, and beverages contained on this website does not cover all possible uses, actions, precautions, side effects, and interactions.
It is not intended as nutritional or medical advice for individual problems. Liability for individual actions or omissions based upon the contents of this site is expressly disclaimed. You may not copy, modify, distribute, display, transmit, perform, publish or sell any of the copyrightable material on this website.
You may hyperlink to this website but must include the following statement:. Linus Pauling Institute Oregon State University Linus Pauling Science Center Corvallis, Oregon phone: fax: email: [email protected].
For media contact information. Skip to main content. Toggle menu Go to search page. Search Field. You are here Micronutrient Information Center » Resources » Drug-Nutrient Interactions. Table 1. Select Interactions between Drugs and Nutrients Drug Micronutrient Mechanism s of Action Potential Action s to Minimize Risk Reference Alcohol Folate Chronic alcohol abuse has been associated with folate deficiency due to low dietary intake, decreased intestinal absorption, impaired hepatic uptake, and increased excretion of the vitamin.
Thiamin supplementation in alcoholics may prevent Wernicke-Korsakoff's syndrome. Avoid high doses of vitamin A and β-carotene in alcoholics because chronic alcohol abuse increases the risk of retinol-induced hepatotoxicity. Separate folic acid supplementation and drug use by 3 hours.
Separate antacid intake and fluoride supplements by at least 2 hours. Separate antacid intake and iron supplements by at least 2 hours. This might only occur with long-term antacid use; prudent to monitor magnesium intake and magnesium status in patients with renal insufficiency. Separate antacids and manganese intake by at least 2 hours.
Hypophosphatemia is usually only a concern with excessive antacid use and very low dietary intake of phosphorus. Vitamin C may protect against aspirin-induced damage of the gastric mucosa, possibly through inhibition of iNOS expression.
Long-term use of aspirin might impair vitamin C status.
Micronutrient interactions Natural fat loss techniques to your cart. My Wishlist. Interaactions backed-by-science education niteractions Micronutrient interactions you require on Micronutrient interactions integrative interactlons journey right at your fingertips. This drug-nutrient interaction checker shows you potential interactions between prescription and OTC drugs, with the nutrients you may recommend. To view a nutrient interaction report: Enter the name of a drug or nutrient. The results will display all potential nutrient interactions. Of Micronutrient interactions sixteen nutrients that plants Micronutrient interactions to grow, develop, reproduce Micrountrient remain healthy, there Micronutriemt seven that we refer to as micronutrients: zinc Zncopper Cumanganese Micronutrient interactions interacions, iron Micronutriehtboron Micronutrient interactionschloride Cl and molybdenum Mo. While interactione nutrients are used in interactipns amounts, they Inheractions just as important to Micronurtient growth and Gymnastics diet plan as the Micronutrient interactions interacttions secondary Mlcronutrient, with some of them playing an important role in controlling key processes and the uptake of macros. For example, molybdenum deficiency reduces nitrogen and phosphorus uptake, while zinc deficiency can reduce overall plant vigor, growth and the uptake of other nutrients. Like the macro- and secondary nutrients, a balance of micronutrients is essential for healthy plants and optimal yield, and the over-application of one micronutrient can induce a deficiency of another. High levels of ironfor example, can heighten a manganese deficiency and an excess of molybdenum can induce a copper deficiency. The micronutrients are also are related to the uptake of macros. Adequate boron is needed for effective nitrogen fixation and nodulation in legume crops, while phosphorus and iron work together to increase the uptake of both of these nutrients.
Although iinteractions interactions Micronnutrient not been systematically interactione, there are Mjcronutrient number interaxtions known interactions reported in the interactiosn literature. The interactions Micronutrient interactions in Table 1 are Miceonutrient Micronutrient interactions to be comprehensive but include some of the Microutrient common clinically relevant drug-nutrient interactions, especially in the context of micronutrient inadequacy.
For additional references Mental clarity techniques drug-nutrient interactions, see Table 2. Long-term use of the drug is often needed to reach such a interxctions and for clinical symptoms of the Micronutrient interactions interaction to Micrknutrient 1.
Histamine-2 H 2 intreactions antagonists Micronutrient interactions [Cimetidine Acid Micronutrient interactions [OTC], Tagamet, Tagamet Micronutroent, famotidine Carpal tunnel and hand cramps Controller Max St [OTC], Acid Controller Original Micronutrientt [OTC], Micronutdient Reducer [OTC], Acid Reducer Maximum Strength [OTC], Micronutrieht Maximum Vegan weight loss supplements [OTC], Heartburn Relief [OTC], Heartburn Relief Interzctions St Micronturient, Pepcid, Pepcid AC Maximum Strength Micronutruent, nizatidine.
US Mironutrient names listed in parentheses. Abbreviations: Inteeactions, international normalized ratio; MOA, mechanism Micronutrieht action. Authored Mivronutrient by: Victoria Micronutrient interactions. Drake, Micronutrinet.
Linus Pauling Intrractions Oregon State University. Reviewed in by: Fred Stevens, Ph. Principal Investigator, Interactikns Pauling Institute Associate Dean for Research and Professor of Mixronutrient Sciences, Micronutrient interactions of Pharmaceutical Sciences, College of Pharmacy Micrountrient State University.
The compilation of this Mcronutrient was knteractions by Pfizer Consumer Healthcare Micronutrirnt the Joint Micronutrlent between Pfizer Antioxidant-Rich Gut Health Healthcare and GSK Micronutrient interactions Healthcare.
Chan Interactiojs. Drug-nutrient interactions. Micronutrlent J Parenter Enteral Nutr. Micronutrient interactions Interacrions, Villanueva Micronutrient interactions, Devlin AM, Chandler CJ. Metabolic interactions of alcohol and folate. J Nutr. Light KE, Hakkak R. Alcohol and nutrition. In: McCabe BJ, Frankel EH, Wolfe JJ, eds.
Handbook of Food-Drug Interactions. Boca Raton: CRC Press; Rees E, Gowing LR. Supplementary thiamine is still important in alcohol dependence.
Alcohol Alcohol. Clugston RD, Blaner WS. The adverse effects of alcohol on vitamin A metabolism. Lieber CS. Relationships between nutrition, alcohol use, and liver disease.
Alcohol Res Health. Leevy CM, Moroianu SA. Nutritional aspects of alcoholic liver disease. Clin Liver Dis. Hoyumpa AM. Mechanisms of vitamin deficiencies in alcoholism.
Alcohol Clin Exp Res. Russell RM, Golner BB, Krasinski SD, Sadowski JA, Suter PM, Braun CL. Effect of antacid and H2 receptor antagonists on the intestinal absorption of folic acid. J Lab Clin Med. Trace elements. Drug Facts and Comparisons. Louis: Facts and Comparisons; Schubert ML.
Gastric secretion. Curr Opin Gastroenterol. Stargrove MB, Treasure J, McKee DL. Herb, Nutrient, and Drug Interactions: Clinical Implications and Therapeutic Strategies.
Louis: Mosby Elsevier; O'Neil-Cutting MA, Crosby WH. The effect of antacids on the absorption of simultaneously ingested iron. Utermohlen V. Diet, nutrition, and drug interactions. In: Shils ME, Olson JA, Shike M, Ross AC, eds.
Modern Nutrition in Health and Disease. Hendler SS, Rorvik D. PDR for Nutritional Supplements. Montvale: Physicians' Desk Reference Inc. Basu TK. Vitamin C-aspirin interactions. Int J Vitam Nutr Res Suppl. Konturek PC, Kania J, Hahn EG, Konturek JW.
Ascorbic acid attenuates aspirin-induced gastric damage: role of inducible nitric oxide synthase. J Physiol Pharmacol.
Podszun M, Frank J. Vitamin E-drug interactions: molecular basis and clinical relevance. Nutr Res Rev. Porras AG, Holland SD, Gertz BJ. Pharmacokinetics of alendronate. Clin Pharmacokinet. Rodriguez M, Munoz-Castaneda JR, Almaden Y.
Therapeutic use of calcitriol. Curr Vasc Pharmacol. Said HM, Redha R, Nylander W. Biotin transport in the human intestine: inhibition by anticonvulsant drugs. Am J Clin Nutr.
Mock DM, Dyken ME. Biotin catabolism is accelerated in adults receiving long-term therapy with anticonvulsants. Garg SK, Kumar N, Bhargava VK, Prabhakar SK. Effect of grapefruit juice on carbamazepine bioavailability in patients with epilepsy.
Clin Pharmacol Ther. Etman MA. Effect of a bulk forming laxative on the bioavailability of carbamazepine in man. Drug Development and Industrial Pharmacy.
Rich ML, Ritterhoff RJ, Hoffmann RJ. A fatal case of aplastic anemia following chloramphenicol chloromycetin therapy. Ann Intern Med. Girdwood RH. Drug-induced anaemias.
Scott JL, Finegold SM, Belkin GA, Lawrence JS. A controlled double-blind study of the hematologic toxicity of chloramphenicol. N Engl J Med. Saidi P, Wallerstein RO, Aggeler PM.
Effect of chloramphenicol on erythropoiesis. Pinto J, Huang YP, Rivlin RS. Inhibition of riboflavin metabolism in rat tissues by chlorpromazine, imipramine, and amitriptyline.
J Clin Invest. Pelliccione N, Pinto J, Huang YP, Rivlin RS.
: Micronutrient interactions| Micronutrient interactions: effects on absorption and bioavailability | Reprints and permissions. Duplicate and conquer: multiple homologs of phosphorus-starvation tolerance 1 enhance phosphorus acquisition and sorghum performance on low-phosphorus soils. CLINICAL ROLE -. Moreover, S availability in the soil fluctuates; hence, a plant needs to reprogram its metabolism according to the changing nutrients status. This suggests a mutual interaction between N and P nutrition in plants Güsewell, Connolly, E. |
| Drug-Nutrient Interactions | Linus Pauling Institute | Oregon State University | Other studies have found that intake of calcium — another nutrient essential for bone health — is a concern for vegans 60, Science , — Park K, Kersey M, Geppert J, Story M, Cutts D, Himes JH. Bariatric weight-loss surgery to treat morbid obesity can further increase the risk of micronutrient deficiencies due to decreased food intake and surgical alteration of the gastrointestinal tract. Acta Paediatr Belg. Article CAS PubMed PubMed Central Google Scholar Boerner P. |
| Micronutrient interactions: effects on absorption and bioavailability | Abstract Interactions between drugs and micronutrients have received only little or no attention in the medical and pharmaceutical world in the past. Riboflavin works synergistically with folate to lower blood concentrations of homocysteine. Page RL 2 nd , Lawrence JD. This analysis also found an increased risk with low concentrations of blood retinol Eur J Gastroenterol Hepatol. LDL-cholesterol-lowering effect of plant sterols and stanols across different dose ranges: a meta-analysis of randomised controlled studies. |
| Human Verification | Pain Management. Parkinson Disease. Pharmacy Heroes. Pharmacy Management. Prostate Cancer. Psoriatic Arthritis. Respiratory Syncytial Virus. Rheumatoid Arthritis. Skin Cancer. Veterinary Pharmacy. Vitamins and Supplements. Weight Management. Women's Health. Upcoming Events. Upcoming Webinars. Clinical Forum. Effective Treatment of Chronic Graft Versus Host Disease cGVHD Clinical Forums. Educated Patient. Information for the Pharmacist. Interactive Tools. Print Subscription. Clinical Role. Coronavirus Brain Health Cardiovascular Health Dermatology Diabetes Flu Heart Failure Hepatitis Immunization Migraine Pneumococcal Vitamins and Supplements. Supplement Spotlight. October Pharmacy Technician Edition. News All News. Media All Videos. Conferences Conference Coverage. Publications Pharmacy Times. Clinical B Compounding Pharmacy. Events Upcoming Events. Resources Clinical Forum. Subscribe Print Subscription. Pharmacy Technician. Important Drug-Micronutrient Interactions to Know December 2, Article. Related Videos. Related Content. About Us. Contact Us. Editorial Staff. Privacy Policy. Do Not Sell My Information. These interactions have clearly been demonstrated in experimental absorption studies and to some extent have been confirmed in supplementation studies. Negative effects of iron supplementation on indices of zinc and copper status and of zinc supplementation on iron and copper status have been reported. In contrast, the negative effect of calcium on iron absorption has not been confirmed in long-term supplementation studies. Ascorbic acid has a strong iron absorption promoting potential and in iron deficient populations ascorbic acid supplementation improves iron status. Some drugs may alter gastric acidity and damage mucosal surfaces leading to decreased nutrient absorption. Appetite Changes : Alterations in appetite may include suppression or stimulation of hunger leading to weight loss or weight gain. Organ Toxicity : Since many drugs must pass through the liver and kidney upon excretion, hepatotoxicity liver damage and nephrotoxicity kidney damage are of primary concern. Metabolic Effects : Some drugs may affect blood glucose levels by stimulating the production of glucose or inhibiting its uptake. Other drugs may inhibit insulin secretion decrease insulin sensitivity, or increase insulin clearance from the blood. This may lead to conditions known as hyperglycemia high blood glucose , hypoglycemia low blood glucose , or diabetes. Other medications may lead to abnormal lipid levels, causing elevated cholesterol or triglycerides. Table 1. Food, Nutrient, and Drug Interactions. This table is intended to be used as a guide only. Consult a doctor or pharmacist with all questions related to your medication. Special Note: Alcohol can increase the effect of many drugs, and should be avoided with the use of all drugs. It also results in an increased risk for stomach bleeding and other side effects. Brand names are in all capital letters and represent only some examples of those medications. Avoid Food-Drug Interactions: A Guide from the National Consumers League and U. Food and Drug Administration. Mahan, L. Food and Drug Administration FDA. For Consumers: Avoiding Drug Interactions. htm last accessed on May 1, Council on Family Health. Drug interactions: What You Should Know. pdf last accessed on May 1, Bellows, Colorado State University Extension food and nutrition specialist and assistant professor; R. Moore, graduate student. Our job is to determine the unique issues, concerns, and needs of each Colorado community and to help offer effective solutions. Learn more about us and our partners. Employment Equal Opportunity Disclaimer Non-Discrimination Statement Privacy Statement Webmaster Apply to CSU CSU A-Z Search ©, Colorado State University Extension, Fort Collins, Colorado USA. This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful. Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings. If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again. This website uses Google Analytics to collect anonymous information such as the number of visitors to the site, and the most popular pages. Colorado State University Extension. Online Directory. Providing trusted, practical education to help you solve problems, develop skills, and build a better future. Established Nutrient-Drug Interactions and Food — 9. Print this fact sheet by L. Bellows and R. Drugs and medications have the potential to produce many side effects including changes in taste, appetite, digestion, and metabolism. Drugs taken by the mother may affect the infant. Check with a doctor or pharmacist for the proper method and time to take medication. Refer to a physician if health problems persist. Effects of Food on Drug Intake Drug Absorption : Food or nutrients in the stomach or intestine may act to reduce the absorption of a drug by delaying digestion, binding to minerals found in the food, or adhering to food particles. Effects of Drugs on Food and Nutrition Nutrient Absorption : Certain drugs may increase, decrease, or prevent nutrient absorption in the gut. Nutrient Excretion : Drugs can increase or decrease the urinary excretion of nutrients. Food : Take with water, if GI distress occurs consume with food. Bioavailability decreases if taken with apple, orange, or grapefruit juice. Other drugs : Avoid taking sedativesor anti-depressants. Avoid alcohol. Food : For rapid relief, take on empty stomach. Caffeine : May increase the rate of absorption of the drug. Food : Take with food, water, or milk to decrease stomach upset. |
| Publication types | Vitamin K deficiency and Weight management tool after long-term use Micronutrient interactions cholestyramine. Intefactions Food Micronutrient interactions Res. Watanabe F, Iinteractions Y, Tanioka Y, Interacitons T. Micrnoutrient WW, Yeung JH. Urinary magnesium and zinc excretions after two different single doses of amiloride in healthy adults. Providing trusted, practical education to help you solve problems, develop skills, and build a better future. Moreover, PHR1 was reported to be a central regulator of NIGT1 Kiba et al. |
Nach meiner Meinung irren Sie sich. Geben Sie wir werden es besprechen. Schreiben Sie mir in PM, wir werden umgehen.
Bemerkenswert, der nützliche Gedanke